Indirect evidence for the role of NK cells in leukemia defense includes the proved decreased incidence of relapse and increased leukemia-free surveillance in the setting of allogenic KIR HLA class I ligand donor-recipient incompatibility hematopoietic stem cell transplantation [21,22]. Here, KIR3DL1 is linked to leukemia.